Identification and characterization of the cellular regulators of Respiratory Syncytial virus infection

Bidragets beskrivning

Respiratory syncytial virus (RSV) is the leading cause of viral infant death in the world. Every year, RSV is responsible for more than 30 million infections in children younger than 5 years of age, of which up to 200.000 die of the disease. In Finland, RSV has a similar incidence. No licenced vaccines are available for RSV. Most antiviral compounds usually target viral components. An alternative strategy is to target the host cell rather than the pathogen. The identification of key cellular regulators of RSV is one of the main goals of current research aimed at developing novel anti-RSV therapies. Using a combination of genetic screening approaches (siRNA and CRISPRs) and a variety of state-of-the-art super-resolution imaging techniques the research presented in this proposal aims at revealing novel cellular regulators of RSV infection and new methods to inhibit it.
Visa mer

Startår

2018

Slutår

2023

Beviljade finansiering

Giuseppe Balistreri Orcid -palvelun logo
438 874 €

Andra beslut

345506
Akademiforskarens forskningskostnader(2021)
139 999 €
319954
Akademiforskarens forskningskostnader(2018)
250 000 €

Finansiär

Finlands Akademi

Typ av finansiering

Akademiforskare

Övriga uppgifter

Finansieringsbeslutets nummer

318434

Vetenskapsområden

Växtbiologi, mikrobiologi, virologi

Forskningsområden

Mikrobiologia

Identifierade teman

covid, pandemic, vaccines